Overview

Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of Brotizolam in the treatment of patients with insomnia in comparison with that of Estazolam
Phase:
Phase 3
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Brotizolam
Estazolam